纳米脂质体伊立替康治疗晚期胆道癌。
Mesh : Humans Irinotecan / therapeutic use administration & dosage Liposomes Biliary Tract Neoplasms / drug therapy pathology Nanoparticles / administration & dosage Antineoplastic Agents, Phytogenic / administration & dosage therapeutic use
来 源: DOI:10.1016/S2468-1253(24)00151-1